Published in Magn Reson Med on September 12, 2015
Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7Tesla. Schizophr Res (2016) 0.75
Glutamine Metabolism in Cancer: Understanding the Heterogeneity. Trends Cancer (2017) 0.75
Creatine, Glutamine plus Glutamate, and Macromolecules Are Decreased in the Central White Matter of Premature Neonates around Term. PLoS One (2016) 0.75
Simultaneous determination of metabolite concentrations, T1 and T2 relaxation times. Magn Reson Med (2017) 0.75
Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med (1993) 15.51
Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed (2000) 8.18
Multimodal image coregistration and partitioning--a unified framework. Neuroimage (1997) 4.26
1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging (2004) 2.47
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain (2005) 2.17
Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med (2004) 2.16
Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med (1998) 2.10
Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med (2003) 1.72
Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage (2004) 1.68
ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed (2006) 1.67
Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med (2001) 1.67
A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex (2001) 1.38
Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging (2010) 1.35
T2 measurement and quantification of glutamate in human brain in vivo. Magn Reson Med (2006) 1.29
Reproducibility of prefrontal γ-aminobutyric acid measurements with J-edited spectroscopy. NMR Biomed (2011) 1.29
Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging (2007) 1.20
Observation of coupled 1H metabolite resonances at long TE. Magn Reson Med (2005) 1.18
Intercellular metabolic compartmentation in the brain: past, present and future. Neurochem Int (2004) 1.13
Functional changes in CSF volume estimated using measurement of water T2 relaxation. Magn Reson Med (2009) 1.12
TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T. Neuroimage (2006) 1.11
Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res (2004) 1.10
Detection of glutamate in the human brain at 3 T using optimized constant time point resolved spectroscopy. Magn Reson Med (2005) 1.04
Measurement of brain glutamate and glutamine by spectrally-selective refocusing at 3 Tesla. Magn Reson Med (2006) 1.03
A new multiple quantum filter design procedure for use on strongly coupled spin systems found in vivo: its application to glutamate. Magn Reson Med (1998) 1.02
Quantitative measurement of N-acetyl-aspartyl-glutamate at 3 T using TE-averaged PRESS spectroscopy and regularized lineshape deconvolution. Magn Reson Med (2011) 1.02
Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1 T. Magn Reson Med (1996) 0.95
Homonuclear J-refocused spectral editing technique for quantification of glutamine and glutamate by 1H NMR spectroscopy. Magn Reson Med (1995) 0.91
Chemical-shift-selective filter for the in vivo detection of J-coupled metabolites at 3T. Magn Reson Med (2005) 0.90
Soft constraints in nonlinear spectral fitting with regularized lineshape deconvolution. Magn Reson Med (2012) 0.83
Exploiting the chemical shift displacement effect in the detection of glutamate and glutamine (Glx) with PRESS. J Magn Reson (2007) 0.83
Quantitative J-resolved prostate spectroscopy using two-dimensional prior-knowledge fitting. Magn Reson Med (2008) 0.83
Regional and tissue-specific differences in brain glutamate concentration measured by in vivo single voxel MRS. J Neurosci Methods (2014) 0.83
In vivo T(2) relaxation time measurement with echo-time averaging. NMR Biomed (2014) 0.79
Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T. NMR Biomed (2012) 0.79
Smoothness of in vivo spectral baseline determined by mean-square error. Magn Reson Med (2013) 0.78
Smoothness of in vivo spectral baseline determined by mean-square error. Magn Reson Med (2013) 0.78